Trademark: 87299360
Word
CUTOMYA
Status
Dead
Status Code
606
Status Date
Monday, February 21, 2022
Serial Number
87299360
Mark Type
4000
Filing Date
Thursday, January 12, 2017
Published for Opposition
Tuesday, May 2, 2017
Abandoned Date
Monday, February 21, 2022

Trademark Owner History
Allergan Sales, LLC - Owner At Publication

Classifications
5 Pharmaceutical preparations used in connection with anti-aging, namely, for use in the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, and for facial aesthetic surgery, facial aesthetic reconstruction, and breast aesthetic treatment procedures; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma agents and decongestant formulations; sterile antibiotic ointments; ocular contact lens wetting solutions, artificial tears and pharmaceutical preparations for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lightener lotions and creams; Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Fertility enhancing pharmaceutical preparations; Pharmaceutical preparations and medicines for the treatment and prevention of sexual dysfunction; Pharmaceutical preparations and medicines for the treatment of sensory organ disorders; Pharmaceutical preparations and medicines for the treatment of central nervous system disorders; Pharmaceutical preparations and medicines for the treatment of urogenital organ disorders; Pharmaceutical preparations and medicines for the treatment of circulatory system disorders; Pharmaceutical preparations and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations and medicines for the treatment and prevention of irritable bowel syndrome; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression; neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceutical and cosmeceutical preparations for skin care, namely, medicated skin cleansers, toners, moisturizers, rejuvenators, rehydrating creams, and lotions for the face and body

Trademark Events
Feb 22, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Feb 21, 2022
Abandonment - No Use Statement Filed
Jul 21, 2021
Notice Of Approval Of Extension Request E-Mailed
Jul 20, 2021
Extension 5 Granted
Jul 12, 2021
Extension 5 Filed
Jul 19, 2021
Case Assigned To Intent To Use Paralegal
Jul 12, 2021
Teas Extension Received
Jan 9, 2021
Notice Of Approval Of Extension Request E-Mailed
Jan 7, 2021
Extension 4 Granted
Jan 7, 2021
Extension 4 Filed
Jan 7, 2021
Teas Extension Received
Jun 30, 2020
Notice Of Approval Of Extension Request E-Mailed
Jun 26, 2020
Extension 3 Granted
Jun 26, 2020
Extension 3 Filed
Jun 26, 2020
Teas Extension Received
Jan 11, 2020
Notice Of Approval Of Extension Request E-Mailed
Jan 9, 2020
Extension 2 Granted
Jan 9, 2020
Extension 2 Filed
Jan 9, 2020
Teas Extension Received
Jun 11, 2019
Notice Of Approval Of Extension Request E-Mailed
Jun 7, 2019
Extension 1 Granted
Jun 7, 2019
Extension 1 Filed
Jun 7, 2019
Teas Extension Received
Jan 15, 2019
Noa E-Mailed - Sou Required From Applicant
Dec 3, 2018
Ttab Release Case To Trademarks
Dec 3, 2018
Opposition Terminated No. 999999
Dec 3, 2018
Opposition Dismissed No. 999999
Aug 30, 2017
Opposition Instituted No. 999999
May 31, 2017
Extension Of Time To Oppose Received
May 2, 2017
Official Gazette Publication Confirmation E-Mailed
May 2, 2017
Published For Opposition
Apr 12, 2017
Notification Of Notice Of Publication E-Mailed
Mar 22, 2017
Approved For Pub - Principal Register
Mar 11, 2017
Assigned To Examiner
Jan 19, 2017
New Application Office Supplied Data Entered In Tram
Jan 16, 2017
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24